[HTML][HTML] 25-hydroxycholesterol in health and diseases

C Nguyen, J Saint-Pol, S Dib, C Pot, F Gosselet - Journal of Lipid Research, 2024 - ASBMB
Cholesterol is an essential structural component of all membranes of mammalian cells
where it plays a fundamental role not only in cellular architecture, but also, for example, in …

[HTML][HTML] Current medical therapy and revascularization in peripheral artery disease of the lower limbs: impacts on subclinical chronic inflammation

AL Cecchini, F Biscetti, M Manzato, L Lo Sasso… - International Journal of …, 2023 - mdpi.com
Peripheral artery disease (PAD), coronary artery disease (CAD), and cerebrovascular
disease (CeVD) are characterized by atherosclerosis and inflammation as their underlying …

Novel soybean polypeptide dglycin alleviates atherosclerosis in apolipoprotein E-deficient mice

H Zhao, P Dan, J Xi, Z Chen, P Zhang, W Wei… - International Journal of …, 2023 - Elsevier
Atherosclerosis is a dominant cause of cardiovascular disease. Accumulation of low-density
lipoproteins (LDL), formation of foam cells, and endothelial dysfunction within the arterial …

The advances in adjuvant therapy for tuberculosis with immunoregulatory compounds

J Mi, X Wu, J Liang - Frontiers in Microbiology, 2024 - frontiersin.org
Tuberculosis (TB) is a chronic bacterial disease, as well as a complex immune disease. The
occurrence, development, and prognosis of TB are not only related to the pathogenicity of …

[HTML][HTML] The protective effects of empagliflozin on DNA oxidative changes in a model of vascular endothelial and smooth muscle cells damaged by oxidized …

E Woźniak, M Świstek, M Broncel, B Bukowska… - Biomedicine & …, 2024 - Elsevier
Background Diabetes patients often suffer chronic vascular complications resulting from
endothelial dysfunction, smooth muscle cell (SMC) proliferation, inflammation and disturbed …

[HTML][HTML] Lipid-Lowering Therapy after Acute Coronary Syndrome

E Pogran, AL Burger, D Zweiker, CC Kaufmann… - Journal of Clinical …, 2024 - mdpi.com
Achieving guideline-recommended low-density lipoprotein cholesterol (LDL-C) targets
remains a significant challenge in clinical practice. This review assesses the barriers to …

Oxysterols in Vascular Cells and Role in Atherosclerosis

C Luquain-Costaz, I Delton - Implication of Oxysterols and Phytosterols in …, 2023 - Springer
Atherosclerosis is a major cardiovascular complication of diseases associated with elevated
oxidative stress such as type 2 diabetes and metabolic syndrome. In these situations, low …

[HTML][HTML] Statin therapy and anthracycline-related cardiac dysfunction: a meta-analysis of randomized clinical trials

W Masson, L Barbagelata, M Lobo… - Acta Oncologica, 2023 - Taylor & Francis
Full article: Statin therapy and anthracycline-related cardiac dysfunction: a meta-analysis of
randomized clinical trials Skip to Main Content Taylor and Francis Online homepage Browse …

[HTML][HTML] Ezetimibe treatment reduces oxidized low-density lipoprotein in biliary cirrhotic rats

CC Chang, HC Huang, SJ Hsu, CK Pun… - Journal of the …, 2024 - journals.lww.com
Background: In liver cirrhosis, chronic inflammation is associated with an increase in
oxidative stress, and subsequently an increase in the concentration of oxidized low-density …

Najnowsze doniesienia naukowe dotyczące właściwości i klinicznego zastosowania rosuwastatyny

E Brociek, K Ozierański - Medycyna Faktów, 2023 - journalsmededu.pl
Statyny stanowią fundament terapii zarówno w prewencji pierwotnej, jak i wtórnej chorób
sercowo-naczyniowych związanych z miażdżycą. Rosuwastatyna, należąca do tzw. silnych …